Gilead Sciences CDR (CAD Hedged) (GILD)

Gilead Sciences CDR (CAD Hedged) (GILD $28.00)
- $28.00 P/E (TTM): 371.34X Cap: $233.46B
- View GILD Profile
- View Questions on GILD

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $477.97)
- $477.97 P/E (TTM): 60.98X Cap: $169.74B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $454.00)
- $454.00 P/E (TTM): 29.96X Cap: $115.33B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $205.07)
- $205.07 P/E (TTM): 87.39X Cap: $362.59B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $235.37)
- $235.37 P/E (TTM): 21.54X Cap: $566.91B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $906.70)
- $906.70 P/E (TTM): 39.98X Cap: $856.66B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $114.18)
- $114.18 P/E (TTM): 15.69X Cap: $282.29B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $161.65)
- $161.65 P/E (TTM): 20.63X Cap: $7.79B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $577.26)
- $577.26 P/E (TTM): 44.33X Cap: $45.90B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $63.43)
- $63.43 P/E (TTM): 25.01X Cap: $7.48B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $90.78)
- $90.78 P/E (TTM): 14.5X Cap: $18.06B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $22.79)
- $22.79 P/E (TTM): 13.21X Cap: $2.78B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $28.00)
- $28.00 P/E (TTM): 371.34X Cap: $233.46B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026